Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1967 2
1968 1
1971 2
1972 1
1973 2
1974 5
1975 5
1977 5
1979 1
1983 3
1984 2
1985 3
1987 1
1988 1
1990 4
1991 1
1992 4
1993 2
1994 2
1995 4
1996 1
1997 1
1998 1
1999 2
2000 3
2001 6
2002 8
2003 7
2004 12
2005 20
2006 16
2007 11
2008 8
2009 16
2010 22
2011 15
2012 13
2013 11
2014 14
2015 30
2016 23
2017 28
2018 24
2019 18
2020 33
2021 42
2022 39
2023 25

Text availability

Article attribute

Article type

Publication date

Search Results

449 results

Results by year

Filters applied: . Clear all
Page 1
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
Dasari A, Lonardi S, Garcia-Carbonero R, Elez E, Yoshino T, Sobrero A, Yao J, García-Alfonso P, Kocsis J, Cubillo Gracian A, Sartore-Bianchi A, Satoh T, Randrian V, Tomasek J, Chong G, Paulson AS, Masuishi T, Jones J, Csőszi T, Cremolini C, Ghiringhelli F, Shergill A, Hochster HS, Krauss J, Bassam A, Ducreux M, Elme A, Faugeras L, Kasper S, Van Cutsem E, Arnold D, Nanda S, Yang Z, Schelman WR, Kania M, Tabernero J, Eng C; FRESCO-2 Study Investigators. Dasari A, et al. Among authors: chong g. Lancet. 2023 Jul 1;402(10395):41-53. doi: 10.1016/S0140-6736(23)00772-9. Epub 2023 Jun 15. Lancet. 2023. PMID: 37331369 Clinical Trial.
Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study.
Wang M, Ramchandren R, Chen R, Karlin L, Chong G, Jurczak W, Wu KL, Bishton M, Collins GP, Eliadis P, Peyrade F, Lee Y, Eckert K, Neuenburg JK, Tam CS. Wang M, et al. Among authors: chong g. J Hematol Oncol. 2021 Oct 30;14(1):179. doi: 10.1186/s13045-021-01188-x. J Hematol Oncol. 2021. PMID: 34717692 Free PMC article. Clinical Trial.
Badminton at nanoscale.
Chong G. Chong G. Nat Chem Biol. 2023 Nov;19(11):1290. doi: 10.1038/s41589-023-01468-2. Nat Chem Biol. 2023. PMID: 37848545 No abstract available.
Pentazocine ulceration.
Irons GB Jr, Hodgkinson DJ, Chong GC, Woods JE. Irons GB Jr, et al. Among authors: chong gc. Ann Plast Surg. 1979 Apr;2(4):286-9. doi: 10.1097/00000637-197904000-00003. Ann Plast Surg. 1979. PMID: 19340995
Current trends of tropical fruit waste utilization.
Cheok CY, Mohd Adzahan N, Abdul Rahman R, Zainal Abedin NH, Hussain N, Sulaiman R, Chong GH. Cheok CY, et al. Among authors: chong gh. Crit Rev Food Sci Nutr. 2018 Feb 11;58(3):335-361. doi: 10.1080/10408398.2016.1176009. Epub 2017 Jun 12. Crit Rev Food Sci Nutr. 2018. PMID: 27246698 Review.
Programmed cell death-1 inhibition in lymphoma.
Hawkes EA, Grigg A, Chong G. Hawkes EA, et al. Among authors: chong g. Lancet Oncol. 2015 May;16(5):e234-45. doi: 10.1016/S1470-2045(15)70103-8. Lancet Oncol. 2015. PMID: 25943068 Review.
Survival of the sweetest tooth.
Chong G. Chong G. Nat Chem Biol. 2023 Dec;19(12):1433. doi: 10.1038/s41589-023-01501-4. Nat Chem Biol. 2023. PMID: 37993615 No abstract available.
449 results